Copyright
©The Author(s) 2025.
World J Gastroenterol. Feb 21, 2025; 31(7): 98448
Published online Feb 21, 2025. doi: 10.3748/wjg.v31.i7.98448
Published online Feb 21, 2025. doi: 10.3748/wjg.v31.i7.98448
Figure 4 The ability of infliximab, ustekinumab, and vedolizumab to achieve endoscopic outcomes in patients with isolated proximal small bowel Crohn’s disease after 1 year of therapy.
A: Complete; B: Jejunum; C: Proximal ileum. aP < 0.05.
- Citation: Huang ZC, Wang BY, Peng B, Liu ZC, Lin HX, Yang QF, Tang J, Chao K, Li M, Gao X, Guo Q. Effectiveness of biologics for endoscopic healing in patients with isolated proximal small bowel Crohn’s disease. World J Gastroenterol 2025; 31(7): 98448
- URL: https://www.wjgnet.com/1007-9327/full/v31/i7/98448.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i7.98448